Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Benzofuranone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110650735A details Pd-catalyzed synthesis of benzofuranone spirocycles. Enables scalable production of immunosuppressive pharmaceutical intermediates with high stereoselectivity.
Patent CN109438402B discloses a green catalytic route for benzofuranone derivatives. High yield, low cost, scalable process ideal for pharmaceutical intermediates manufacturing.
Novel patent CN108623456A offers mild conditions for butylphthalide. Reduces cost and improves safety for reliable pharmaceutical intermediate supplier.
Novel patent CN108752299A enables mild 3-benzofuranones synthesis. Offers supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing for global buyers.
Patent CN109503532A reveals catalyst-free green synthesis route. Offers high yield and significant cost reduction for pharmaceutical intermediates manufacturing supply chain reliability.